ClinicalTrials.Veeva

Menu

Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE

University of Washington logo

University of Washington

Status

Active, not recruiting

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Depression
Malignant Solid Neoplasm

Treatments

Other: Collaborative care
Other: Survey Administration
Other: Interview or Focus Group
Other: Media/technology Intervention with collaborative care

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05012124
STUDY00012892 (Other Identifier)
RG1121503
NCI-2021-07762 (Registry Identifier)
R01CA244171 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study compares the effectiveness of technology-enhanced collaborative care management (t-CoCM) to usual collaborative care management (u-CoCM) in achieving fidelity to processes of care and reducing depression symptoms in patients currently receiving cancer treatment. CoCM is a population-based, integrated care approach, where care managers, who are clinicians (typically clinical social workers), deliver behavioral treatments, coordinate psychosocial care, monitor outcomes, and adjust treatment with the input of a psychiatric consultant. The use of t-CoCM may improve the treatment of depression and improve patient outcomes and quality of life.

Full description

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I (t-CoCM): Patients use the t-CoCM digital app platform and clinic care managers use the t-CoCM web-based patient registry platform to support delivery of collaborative care. Patients complete surveys at baseline, 3, 6 and 9 months. Some patients also participate in an interview or focus group about their user experience with the t-CoCM digital platform. Care managers also participate in interviews or focus groups regarding their experience with CoCM and the newly developed web-based platform.

ARM II (u-CoCM): Patients receive usual care and clinic care managers deliver usual CoCM. Patients complete surveys at baseline, 3, 6 and 9 months.

Enrollment

297 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients receiving active treatment (surgery, chemotherapy, immunotherapy, targeted therapy, stem cell transplant, hormone therapy, radiation therapy) for a malignancy

  • >= 18 years old

  • Participants must be ambulatory for clinical care visits

  • Clinically significant depression (Patient Health Questionnaire-9 (PHQ-9) >= 10 with at least one cardinal symptom > 1)

  • Access to smartphone, tablet, or computer with internet access; or landline

    • Patients who do not have a smartphone will be offered assistance in obtaining a free smartphone through the government-sponsored Lifeline Phone Program for low-resourced individuals

Exclusion criteria

  • Advanced cancer or other condition that limits remaining life expectancy to less than 9 months
  • Already engaged in or needing immediate specialty mental health care e.g., for bipolar disorder or schizophrenia
  • Inability to speak and read English

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

297 participants in 2 patient groups

Arm I (t-CoCM)
Experimental group
Description:
Patients use the t-CoCM digital app platform and clinic care managers use the t-CoCM web-based registry platform to support delivery of collaborative care. Patient's complete surveys at baseline, 3, 6 and 9 months. Some patients also participate in an interview or focus group about their user experience with the t-CoCM digital platform. Care managers also participate in interviews regarding their experience with CoCM and the newly developed web-based platform.
Treatment:
Other: Media/technology Intervention with collaborative care
Other: Interview or Focus Group
Other: Survey Administration
Arm II (u-CoCM)
Active Comparator group
Description:
Patients receive usual care and clinic care managers deliver usual CoCM. Patients complete surveys at baseline, 3, 6 and 9 months.
Treatment:
Other: Survey Administration
Other: Collaborative care

Trial documents
1

Trial contacts and locations

4

Loading...

Central trial contact

Jesse R. Fann

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems